2YFX | Transferase | date | Apr 08, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Com Crizotinib | ||||||||||||||
authors | M.Mctigue, Y.Deng, W.Liu, A.Brooun | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Tyrosine-Protein Kinase Receptor Chain: A Fragment: Kinase Domain, Residues 105-423 Synonym: Anaplastic Lymphoma Kinase Ec: 2.7.10.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Spodoptera Frugiperda Expression_system_common: Fall Armyworm Expression_system_taxid: 7108 Expression_system_cell_line: Sf9 Expression_system_vector_type: Baculovirus Expression_system_plasmid: Pfastbac | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.70 Å | ||||||||||||
ligand | VGH BindingDB | enzyme | Transferase E.C.2.7.10.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | The design of potent and selective inhibitors to overcome clinical ALK mutations resistant to crizotinib., Huang Q, Johnson TW, Bailey S, Brooun A, Bunker KD, Burke BJ, Collins MR, Cook A, Cui JJ, Dack KN, Deal JG, Deng YL, Dinh DM, Engstrom LD, He M, Hoffman J, Hoffman RL, Shen H, Johnson P, Kania RS, Lam H, Lam JL, Le P, Li Q, Lingardo L, Liu W, West Lu M, McTigue MA, Palmer CL, Richardson PF, Sach NW, Smeal T, Smith GL, Stewart AE, Timofeevski SL, Tsaparikos K, Wang H, Zhu H, Zhu J, Zou HY, Edwards M, J Med Chem. 2014 Jan 16. PMID:24432909 |
Data retrieval |
View 2YFX in 3D |
Visual 3D analysis of 2YFX |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2YFX |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |